发明授权
- 专利标题: Imidazole derivatives
- 专利标题(中): 咪唑衍生物
-
申请号: US12440237申请日: 2007-09-05
-
公开(公告)号: US08273738B2公开(公告)日: 2012-09-25
- 发明人: Naoto Osakada , Mariko Osakada , Takashi Sawada , Satoshi Kaneko , Atsuko Mizutani , Noriaki Uesaka , Yoshisuke Nakasato , Keishi Katayama , Masamori Sugawara , Yushi Kitamura
- 申请人: Naoto Osakada , Mariko Osakada , Takashi Sawada , Satoshi Kaneko , Atsuko Mizutani , Noriaki Uesaka , Yoshisuke Nakasato , Keishi Katayama , Masamori Sugawara , Yushi Kitamura
- 申请人地址: JP Tokyo
- 专利权人: Kyowa Hakko Kirin Co., Ltd.
- 当前专利权人: Kyowa Hakko Kirin Co., Ltd.
- 当前专利权人地址: JP Tokyo
- 代理机构: Edwards Wildman Palmer LLP
- 代理商 David G. Conlin; Mark D. Russett
- 优先权: JP2006-239907 20060905
- 国际申请: PCT/JP2007/067261 WO 20070905
- 国际公布: WO2008/029825 WO 20080313
- 主分类号: A61K31/535
- IPC分类号: A61K31/535 ; A61K31/4965
摘要:
A CB2 receptor modulator comprising an imidazole derivative represented by the general formula (I): [wherein, R1 represents optionally substituted lower alkyl or the like; R2 represents optionally substituted cycloalkyl or the like; R3 represents optionally substituted aryl or the like; and n represents an integer of 0 to 3] or a pharmaceutically acceptable salt thereof as an active ingredient, and the like are provided.
公开/授权文献
- US20100152178A1 IMIDAZOLE DERIVATIVES 公开/授权日:2010-06-17
信息查询